HIGHLIGHTS
- who: Amirhossein Mardi from the (UNIVERSITY) have published the research work: Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction, in the Journal: (JOURNAL)
- what: The authors provide a review of the biological causes of ICD and its potential role in the induction of anti-tumor immunity through OVs replication within cancer cells, and also the synergistic combination of OVs with CAR T-cell to achieve potent tumor-specific immunity. This approach has been used in a number . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.